Optimize Your RNAi experiments
The siRNA sequences comprising MISSION™ siRNA libraries have been optimized for performance in RNAi experiments using a best-in-class set of design rules developed by Rossetta Inpharmatics, a wholly owned subsidiary of Merck and Company, Inc., and a recognized leader in the field of bioinformatics. Specifically, design rules in the current Rosetta algorithm have been optimized with over three years of continuous development, leading to siRNA of increased target specificity and improved knockdown of messages across the entire genome, as proven in use in drug discovery research. For more information, please visit the link below.
|
